Literature DB >> 2549888

Crystal deposition in hypophosphatasia: a reappraisal.

A J Chuck1, M G Pattrick, E Hamilton, R Wilson, M Doherty.   

Abstract

Six subjects (three female, three male; age range 38-85 years) with adult onset hypophosphatasia are described. Three presented atypically with calcific periarthritis (due to apatite) in the absence of osteopenia; two had classical presentation with osteopenic fracture; and one was the asymptomatic father of one of the patients with calcific periarthritis. All three subjects over age 70 had isolated polyarticular chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition; four of the six had spinal hyperostosis, extensive in two (Forestier's disease). The apparent paradoxical association of hypophosphatasia with calcific periarthritis and spinal hyperostosis is discussed in relation to the known effects of inorganic pyrophosphate on apatite crystal nucleation and growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549888      PMCID: PMC1003818          DOI: 10.1136/ard.48.7.571

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.

Authors:  R G Russell; H Fleisch
Journal:  Clin Orthop Relat Res       Date:  1975-05       Impact factor: 4.176

Review 2.  Crystal deposition disease in the elderly.

Authors:  M Doherty; P Dieppe
Journal:  Clin Rheum Dis       Date:  1986-04

3.  [Isolated chondrocalcinosis manifesting as hypophosphatasia in adults. 2 cases and review of the literature].

Authors:  J L Pinquier; H Awada; F Delrieu; B Amor
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-06

4.  Tumor-like soft tissue swelling of the distal phalanx due to calcium pyrophosphate dihydrate crystal deposition.

Authors:  H R Schumacher; H Bonner; J J Thompson; W L Kester; J J Benner
Journal:  Arthritis Rheum       Date:  1984-12

5.  Matrix vesicle enzymes in human osteoarthritis.

Authors:  T A Einhorn; S L Gordon; S A Siegel; C F Hummel; M J Avitable; R P Carty
Journal:  J Orthop Res       Date:  1985       Impact factor: 3.494

6.  Hypomagnesemia due to renal disease of unknown etiology.

Authors:  L Runeberg; Y Collan; E J Jokinen; J Lähdevirta; A Aro
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

7.  Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations.

Authors:  D Resnick; S R Shaul; J M Robins
Journal:  Radiology       Date:  1975-06       Impact factor: 11.105

8.  Ectopic calcification in hypophosphatasia.

Authors:  J D Macfarlane; H M Kroon; A Cats
Journal:  Eur J Radiol       Date:  1986-08       Impact factor: 3.528

9.  The deposition of calcium pyrophosphate and phosphate by matrix vesicles isolated from fetal bovine epiphyseal cartilage.

Authors:  H H Hsu; H C Anderson
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

10.  Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone.

Authors:  R G Russell; S Bisaz; A Donath; D B Morgan; H Fleisch
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

View more
  17 in total

1.  Adult hypophosphatasia with painful periarticular calcification treated with surgical resection.

Authors:  Kei-Ichiro Iida; Jun-Ichi Fukushi; Toshifumi Fujiwara; Yoshinao Oda; Yukihide Iwamoto
Journal:  J Bone Miner Metab       Date:  2011-12-15       Impact factor: 2.626

2.  Mutational and biochemical findings in adults with persistent hypophosphatasemia.

Authors:  F E McKiernan; J Dong; R L Berg; E Scotty; P Mundt; L Larson; I Rai
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

3.  Whole-body MRI in the childhood form of hypophosphatasia.

Authors:  C Beck; H Morbach; C Wirth; M Beer; H J Girschick
Journal:  Rheumatol Int       Date:  2010-04-10       Impact factor: 2.631

Review 4.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

5.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Orthopade       Date:  2010-06       Impact factor: 1.087

Review 6.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

7.  Osteomalacia revisited : a report on 28 cases.

Authors:  Laia Gifre; Pilar Peris; Ana Monegal; Maria Jesús Martinez de Osaba; Luisa Alvarez; Núria Guañabens
Journal:  Clin Rheumatol       Date:  2010-10-15       Impact factor: 2.980

Review 8.  How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?

Authors:  C Beck; H Morbach; P Richl; M Stenzel; H J Girschick
Journal:  Rheumatol Int       Date:  2008-09-28       Impact factor: 2.631

9.  Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.

Authors:  M Pattrick; E Hamilton; J Hornby; M Doherty
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

Review 10.  Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23.

Authors:  Nobuaki Ito; Seiji Fukumoto
Journal:  Calcif Tissue Int       Date:  2020-01-22       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.